What is Bioelements?
Bioelements operates at the intersection of dermatological science and natural formulation, providing a comprehensive suite of professional-grade skincare treatments. The company distinguishes itself through a dual-market strategy, serving licensed skin care professionals with specialized clinical formulas while simultaneously offering high-efficacy solutions for home users. By addressing complex dermatological concerns such as acne, premature aging, and chronic dehydration, Bioelements has established a reputation for clinical rigor and product innovation. Their business model leverages the trust inherent in professional esthetician recommendations, creating a sustainable competitive advantage in the highly fragmented beauty and wellness industry.
How much funding has Bioelements raised?
Bioelements has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bioelements
PPP
Public-Private Partnership
What's next for Bioelements?
Following this late-stage financing, Bioelements is expected to prioritize the expansion of its digital infrastructure and the optimization of its supply chain to meet rising global demand. The strategic allocation of these funds will likely focus on research and development to pioneer new, science-backed formulations that address emerging skin health trends. Furthermore, the company is poised to enhance its educational platforms for skincare professionals, reinforcing its status as a thought leader in the industry. By scaling its distribution networks and investing in brand equity, Bioelements aims to solidify its market share against both legacy beauty conglomerates and emerging boutique skincare brands, ensuring long-term value creation for its stakeholders.
See full Bioelements company page
